Ready to play
Ready to play
A clinical study from Yonsei University in Korea has shown that direct oral anticoagulants reduce the risk of stroke and serious complications by 69% in patients with moderate to high-risk atrial fibrillation, without increasing the risk of severe bleeding. The study confirmed that treatment significantly decreases the occurrence of stroke or cardiac-related death within two years, representing the first evidence of the benefits of these medications for patients with moderate risk.
Notice: This Is an AI-Generated Summary
Comments (0)